Skip to content
ClinCalc Pro
Menu
Androgen — Male Hypogonadism

Testosterone

Brand names: Testogel (gel), Nebido (IM depot), Testim (gel), Sustanon (IM)

Testosterone replacement therapy, available as gels, transdermal and injectable preparations, is used to treat confirmed male hypogonadism (testosterone deficiency).

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It replaces endogenous androgen, binding androgen receptors to restore secondary sexual characteristics, libido, muscle and bone mass, and to suppress the symptoms of deficiency.

Prescribing in practice

  • It is contraindicated in known or suspected prostate or breast cancer and must only be started after biochemically confirmed deficiency on morning samples.
  • Therapy can raise haematocrit (causing polycythaemia and thrombotic risk) and may worsen lower urinary tract symptoms or unmask prostate disease.
  • Topical gels can transfer to partners and children on skin contact, so application sites should be covered and washed.

Monitoring

Monitor testosterone levels, haematocrit, prostate-specific antigen and prostate symptoms before and periodically during treatment.

Counselling the patient

  • With gels, cover the application area and avoid skin-to-skin contact with women and children until absorbed.
  • Attend blood tests as scheduled to check red cell count and prostate marker.

Evidence & guidelines

Endocrine and urology guidelines recommend testosterone replacement only for symptomatic, biochemically confirmed hypogonadism, with structured safety monitoring.

Reference: NICE NG227 (Testosterone for male hypogonadism); EAU Male Hypogonadism Guidelines 2024; Endocrine Society Guidelines 2018; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.